RuthL.KatzMD

Cytopathology, Anatomic Pathology, Clinical Pathology

Academic cytopathology

Dr. Katz is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

University of Texas Health Science Center at HoustonResidency, Pathology-Anatomic and Clinical, 1978 - 1979
University of Texas M D Anderson Cancer CenterFellowship, Cytopathology, 1978 - 1979
Tufts Medical CenterResidency, Pathology-Anatomic and Clinical, 1976 - 1978
University of the WitwatersrandClass of 1969

PubMed

161 citations
PTEN genomic deletion is associated with p-Akt and AR signalling in poorer outcome, hormone refractory prostate cancer.
Kanishka Sircar, Maisa Yoshimoto, Federico A. Monzon, Ismaël Hervé Koumakpayi, Ruth L. Katz
The Journal of Pathology. 2009-08-01
68 citations
Leptomeningeal disease and breast cancer: The importance of tumor subtype
Sausan Abouharb, Joe Ensor, Monica Loghin, Ruth L. Katz, Stacy L. Moulder
Breast Cancer Research and Treatment. 2014-07-20
439 citations
High Rate of Durable Remissions After Treatment of Newly Diagnosed Aggressive Mantle-Cell Lymphoma With Rituximab Plus Hyper-CVAD Alternating With Rituximab Plus High-...
Jorge E. Romaguera, Luis Fayad, Maria A Rodriguez, Kristine Broglio, Frederick B. Hagemeister
Journal of Clinical Oncology. 2005-10-01

Episode 4: Addressing the Recent Trends in the Opioid EpidemicSeptember 29th, 2021
17th Assistant Secretary for Health, Dr. Rachel L. Levine, Joins National Academy of Medicine Action Collaborative on Countering the U.S. Opioid Epidemic as Co-ChairJuly 20th, 2021
Familiar Faces at Aspen Ideas: Health, Set April 27-29April 8th, 2021
Join now to see all